StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · MASS·Healthcare

908 Devices Inc. Stock Analysis & AI Score

908 Devices Inc. (MASS) has an ST Score of 50.7 (C+), driven by its Momentum (A) and held back by its Valuation (D). Analysts rate it Buy with a $12.00 price target (+4.2% upside).

Market Closed
$11.52
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
51
ST Score
50.7/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Specialties
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

MASS
50.7out of 100
Grade C+

908 Devices Inc. (MASS) has an ST Score of 50.7 (C+), driven by its Momentum (A) and held back by its Valuation (D). Analysts rate it Buy with a $12.00 price target (+4.2% upside).

Strongest
MomentumA
Weakest
ValuationD
All factor grades
  • MomentumA
  • Financial StrengthA-
  • GrowthB-
  • ForecastC+
  • ProfitabilityC-
  • ValuationD
  • Piotroski3/9
Score methodology
Press Releases

Contact

MASS stock: frequently asked questions

What is MASS's ST Score?

908 Devices Inc. (MASS) has an ST Score of 50.7 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is MASS a buy, hold, or sell?

Analysts rate MASS a Buy, with a price target of $12.00 (+4.2% vs the current price). Our ST Score grades it C+ (50.7/100). The ST Score is a data-driven signal, not a recommendation.

What are MASS's factor grades?

Valuation D, Profitability C-, Financial Strength A-, Momentum A, Growth B-, Forecast C+.

What is MASS's valuation grade?

908 Devices Inc. (MASS) earns a valuation grade of D, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is MASS's growth grade?

908 Devices Inc. (MASS) earns a growth grade of B-, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is MASS's profitability grade?

908 Devices Inc. (MASS) earns a profitability grade of C-, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is MASS's financial strength grade?

908 Devices Inc. (MASS) earns a financial strength grade of A-, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for MASS?

The average analyst price target for 908 Devices Inc. (MASS) is $12.00 from 6 analysts, which is +4.2% versus the recent price of $11.52.

What is MASS's Piotroski score?

908 Devices Inc. (MASS) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.